» Articles » PMID: 34176482

Circulating ERBB3 Levels Are Inversely Associated with the Risk of Overweight-related Hypertension: a Cross-sectional Study

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2021 Jun 28
PMID 34176482
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension and overweight are independent risk factors for cardiovascular disease, and overweight increase the risk of developing high blood pressure. ERBB3( also known as HER3) plays a considerable role in the development of cardiovascular diseases. However, the effect of ERBB3 levels in hypertensive overweight patients is unknown. The aim of this study was to assess the association between ERBB3 levels and hypertension in overweight Chinese patients.

Methods: We evaluated the height,weight, blood pressure, biochemical indicators, and ERBB3 levels in 128 Chinese adults aged 33-79 years. Plasma ERBB3 levels were assessed by the enzyme-linked immunosorbent assay, and body mass index(BMI) was calculated as body weight divided by height squared. Participants were allocated into three groups according to blood pressure and BMI: healthy control (CNT, n = 31; normotensive and non-overweight), hypertension (HT, n = 33; hypertension and non-overweight), and hypertension with overweight (HTO, n = 64; hypertension and overweight). Statistical significance was defined as a two-tailed P < 0.05.

Results: There was no significant difference in mean ERBB3 levels among the three groups, although a linear decrease from CNT (1.13 ± 0.36), HT (1.03 ± 0.36), to HTO (0.84 ± 0.26 ng/mL) was observed in men (P = 0.007). Among the drinking population, the ERBB3 level was significantly reduced in the HTO group as compared with those of the CNT and HT groups (0.76 ± 0.23 versus 1.18 ± 0.37 and 1.20 ± 0.30, respectively). ERBB3 levels were negatively correlated with diastolic blood pressure in men (r= - 0.293, P = 0.012), smoking (r= - 0.47, P = 0.004), and drinking (r = - 0.387, P = 0.008). BMI in men and among drinkers, and uric acid among drinkers were negatively correlated with ERBB3 levels. Multivariate conditional logistic regression showed that plasma ERBB3 levels were associated with a reduced risk of HTO in men [odds ratio (OR) 0.054; 95 % confidence interval (CI): 0.007-0.412) and drinkers (OR 0.002; 95 % CI: 0.000-0.101).

Conclusions: ERBB3 may contribute to the pathogenesis of hypertension in overweight patients, with BMI, gender, and drinking all potentially modulating the process.

Citing Articles

Overweight-Related Hypertension in Middle-Aged Men Is Linked to Elevated Leptin, TNF-α, IL-6, Cholesterol, and Reduced Testosterone.

Alaamri S, Serafi A, Hussain Z, Bafail S, Bafail M, Demirkhanyan L Pathophysiology. 2025; 32(1).

PMID: 39982363 PMC: 11843874. DOI: 10.3390/pathophysiology32010007.

References
1.
Ottolini M, Hong K, Cope E, Daneva Z, DeLalio L, Sokolowski J . Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity. Circulation. 2020; 141(16):1318-1333. PMC: 7195859. DOI: 10.1161/CIRCULATIONAHA.119.043385. View

2.
Wiinberg N, Hoegholm A, Christensen H, Bang L, Mikkelsen K, Nielsen P . 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens. 1995; 8(10 Pt 1):978-86. DOI: 10.1016/0895-7061(95)00216-2. View

3.
Wilson P, DAgostino R, Sullivan L, Parise H, Kannel W . Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162(16):1867-72. DOI: 10.1001/archinte.162.16.1867. View

4.
Yarden Y, Sliwkowski M . Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001; 2(2):127-37. DOI: 10.1038/35052073. View

5.
Jin Q, Esteva F . Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia. 2008; 13(4):485-98. DOI: 10.1007/s10911-008-9107-3. View